Quantcast

Latest University of Texas Health Science Center at San Antonio Stories

2009-07-02 12:45:00

Middle school students who were part of a unique science learning program developed by The University of Texas School of Public Health showed significant increases in interest and achievement scores compared to other students, a recent study found.Results from the study are published in the June issue of the Association of American Medical Colleges' Academic Medicine.  The program, HEADS UP (Health Education and Discovering Science while Unlocking Potential), presents key science...

2009-02-04 11:15:00

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) and the Cancer Therapy & Research Center at The University of Texas Health Science Center in San Antonio, (CTRC at UTHSCSA) announced a broad preclinical and clinical collaboration involving up to five, open-label, Phase 2 studies exploring the use of REOLYSIN(R) in combination with chemotherapy for various cancer indications. These indications are expected to include melanoma,...

2008-10-06 15:00:41

LOS ANGELES, Oct. 6, 2008 (GLOBE NEWSWIRE) -- Charles Drew University of Medicine and Science (CDU) has been awarded a major $15 million endowment grant that will significantly expand its medical research infrastructure and capacity from the National Institutes of Health, through its National Center for Minority Health and Health Disparities (NCMHD), it was announced today by Dr. Susan Kelly, President and CEO of CDU. With the new grant, the university's research endowment base will grow to...

2008-09-29 21:00:31

By Daniel Connolly The Regional Medical Center at Memphis plans to ask the University of Tennessee Health Science Center about participating in its plan to build a new clinical office on Union that would attract paying patients. The Med's interest in the project reflects its desire to earn money and turn around a projected $14.4 million operating loss this fiscal year. Hospital board chairman Gene Holcomb said Thursday that he wants The Med's new interim CEO, Claude Watts Jr., to...

2008-09-16 12:00:50

Three internationally known pediatric surgeons from The University of Texas Health Science Center at San Antonio and its academic children's hospital, CHRISTUS Santa Rosa Children's Hospital, are this year's recipients of the prestigious Julio Palmaz Award for Innovation in Healthcare and the Biosciences. Robert M. Campbell, Jr., M.D., Melvin D. Smith, M.D. (deceased) and Kaye E. Wilkins, D.V.M., M.D. are each being honored for devising innovative ideas that have had tangible, life-saving...

2008-09-15 12:00:35

SCOTTSDALE, Ariz., Sept. 15 /PRNewswire/ -- Carefx Corporation today announced that the nationally recognized Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio, Texas, has gone live after a 90-day implementation with Fusion from Carefx(R), an interoperability platform that aligns patient data across multiple applications to provide a complete view of patient health history. One of only three National Cancer Institute-designated...

2008-09-05 06:00:23

US-based pharmaceutical company Azaya Therapeutics has signed a licensing agreement to further develop a technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying recurrence and avoiding the collateral tissue damage that often accompanies all other forms of radiation therapy. The company plans to begin a Phase I clinical trial in early 2010. Azaya is licensing the technology, now known as Azaya Liposomal...

2008-09-03 12:00:33

Azaya Therapeutics, Inc., announced today that it has signed a licensing agreement to further develop a breakthrough technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying recurrence and avoiding the collateral tissue damage that often accompanies all other forms of radiation therapy. The company plans to begin a phase I clinical trial in early 2010. Azaya is licensing the technology, now known as Azaya...

2008-06-20 03:00:29

CALGARY, June 20 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers. The Principal Investigator is Dr. Monica Mita of the Cancer Therapy and Research Center, University of Texas...

2007-08-09 12:04:00

Michael J. Wick, Ph.D., a recognized leader in the research of new anti-cancer drugs, has been named director of preclinical research at South Texas Accelerated Research Therapeutics (START). He will join the START team on Sept. 3. Dr. Wick comes to START from the Cancer Therapy & Research Center's (CTRC) Institute for Drug Development, where he was director of preclinical research. He is a recognized expert in the testing of novel therapies in animal models of human cancer....


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related